 Connection
Edward Janoff to Amphotericin B
This is a "connection" page, showing publications Edward Janoff has written about Amphotericin B.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.290 |
|
|
|
-
Kline S, Larsen TA, Fieber L, Fishbach R, Greenwood M, Harris R, Kline MW, Tennican PO, Janoff EN. Limited toxicity of prolonged therapy with high doses of amphotericin B lipid complex. Clin Infect Dis. 1995 Nov; 21(5):1154-8.
Score: 0.116
-
Janoff EN, Frank DN. Pathogen-specific antibodies: codependent no longer. J Clin Invest. 2010 Apr; 120(4):1039-42.
Score: 0.079
-
Kambugu A, Meya DB, Rhein J, O'Brien M, Janoff EN, Ronald AR, Kamya MR, Mayanja-Kizza H, Sande MA, Bohjanen PR, Boulware DR. Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy. Clin Infect Dis. 2008 Jun 01; 46(11):1694-701.
Score: 0.069
-
Boulware DR, Meya DB, Muzoora C, Rolfes MA, Huppler Hullsiek K, Musubire A, Taseera K, Nabeta HW, Schutz C, Williams DA, Rajasingham R, Rhein J, Thienemann F, Lo MW, Nielsen K, Bergemann TL, Kambugu A, Manabe YC, Janoff EN, Bohjanen PR, Meintjes G. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. N Engl J Med. 2014 Jun 26; 370(26):2487-98.
Score: 0.026
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|